Sign Up to like & get
recommendations!
1
Published in 2018 at "Translational Oncology"
DOI: 10.1016/j.tranon.2018.03.004
Abstract: Patients with breast cancer (BC) overexpressing HER2 (HER2+) are selected for Trastuzumab treatment, which blocks HER2 and improves cancer prognosis. However, HER2+ diagnosis, by the gold standard, immunohistochemistry, could lead to errors, associated to: a)…
read more here.
Keywords:
detection;
affibody quantum;
ratiometric analysis;
her2 ... See more keywords